Background: Follicular thyroid tumors (FTT) usually require resection to distinguish adenoma from carcinoma. Better markers that predict histologic subtype and prognosis are needed for FTT.
Methods: Seventeen benign and malignant FTT with follow-up were selected. Pathologic diagnosis was confirmed, tumor and normal tissue were microdissected, and DNA was extracted. Polymerase chain reaction (PCR) products for a microsatellite marker at the von Hippel Lindau gene (VHL) gene locus (3p26) were analyzed with semiquantitative capillary gel electrophoresis to detect loss of heterozygosity (LOH). Data were assessed for statistical significance with chi(2).
Results: Mean follow-up was 77 months (range 29 to 120 months). Four cases were uninformative (homozygous microsatellite). Among 13 evaluable patients (6 adenomas, 7 follicular cancers) LOH of VHL was present only in carcinomas (P=.013). LOH was present in 4/4 patients with recurrence and 0/3 patients without recurrence (P=.017). Death from disease has occurred in 3 patients. LOH of VHL was strongly associated with death from disease (P=.034).
Conclusions: FTT can be analyzed for LOH at the VHL gene locus. In this initial study, LOH of VHL was highly specific for malignancy and predicted death from disease. The analysis of VHL may provide for preoperative detection in cytologic samples with potential impact on clinical management of FTT.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.surg.2003.07.023 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinicopathological and molecular features of renal cell carcinomas with haemangioblastoma-like features distinct from clear cell renal cell carcinoma.
Histopathology
February 2024
Department of Human Pathology, Wakayama Medical University, Wakayama, Japan.
Article Synopsis
- - The study focuses on rare renal cell carcinomas (RCCs) that show features similar to haemangioblastomas, with a specific look at their clinicopathological characteristics and VHL gene alterations, comparing them to clear cell renal cell carcinomas (CCRCCs) that also exhibit these features.
- - The identified RCCs with haemangioblastoma-like features are generally indolent, have a distinct appearance with a thick capsule, and specific immunohistochemical profiles, but do not show typical VHL mutations, indicating a different molecular behavior.
- - Findings suggest these RCCs can be differentiated from CCRCCs, as they exhibit unique features in terms of blood vessel and cell structure, as well as differences in genetic mutations
Novel Germline Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia.
Medicina (Kaunas)
August 2022
Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50139 Florence, Italy.
Background: Pheochromocytoma (Pheo) and paraganglioma (PGL) are rare tumors, mostly resulting from pathogenic variants of predisposing genes, with a genetic contribution that now stands at around 70%. Germline variants account for approximately 40%, while the remaining 30% is attributable to somatic variants. Objective: This study aimed to describe a new PHD2 (EGLN1) variant in a patient affected by metastatic Pheo and chronic myeloid leukemia (CML) without polycythemia and to emphasize the need to adopt a comprehensive next-generation sequencing (NGS) panel.
View Article and Find Full Text PDFAn optimized protocol for evaluating pathogenicity of germline variants in patients suspected with von Hippel-Lindau syndrome: Using somatic genome to inform the role of germline variants.
MethodsX
June 2022
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Article Synopsis
- * Current guidelines for assessing germline variants don't adequately incorporate data from tumors, which can be crucial for understanding their significance in cancer cases.
- * The authors present an optimized protocol that utilizes somatic tumor profiling to better evaluate the pathogenicity of germline variants, including details about case selection and key supporting evidence like loss of heterozygosity (LOH).
Pathogenic ATM and BAP1 germline mutations in a case of early-onset, familial sarcomatoid renal cancer.
Cold Spring Harb Mol Case Stud
April 2022
University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Metastatic renal cell carcinoma (RCC) remains an incurable malignancy, despite recent advances in systemic therapies. Genetic syndromes associated with kidney cancer account for only 5%-8% of all diagnosed kidney malignancies, and genetic predispositions to kidney cancer predisposition are still being studied. Genomic testing for kidney cancer is useful for disease molecular subtyping but provides minimal therapeutic information.
View Article and Find Full Text PDFClinical relevance of screening checklists for detecting cancer predisposition syndromes in Asian childhood tumours.
NPJ Genom Med
November 2018
1Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610 Singapore.
Assessment of cancer predisposition syndromes (CPS) in childhood tumours is challenging to paediatric oncologists due to inconsistent recognizable clinical phenotypes and family histories, especially in cohorts with unknown prevalence of germline mutations. Screening checklists were developed to facilitate CPS detection in paediatric patients; however, their clinical value have yet been validated. Our study aims to assess the utility of clinical screening checklists validated by genetic sequencing in an Asian cohort of childhood tumours.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!